InvestorBrandNetworknews

Regentis Biomaterials and the Shift from Symptom Management to Structural Repair in Knee Cartilage Care

Monday, September 28, 2026IBN.aiView original
For much of the last three decades, treatment of degenerative knee disease has centered heavily on managing symptoms with anti-inflammatories, activity modification, lubricants and injections, while structural intervention was often reserved for more advanced disease. Focal cartilage defects had surgical options, but those came with their own tradeoffs in durability, complexity, and cost. That balance […]